Diagnosis and non-surgical treatment of peri-implant diseases and maintenance care of patients with dental implants - Consensus report of working group 3.

Peri-implant diseases maintenance non-surgical therapy peri-implant mucositis peri-implantitis supportive care

Journal

International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714

Informations de publication

Date de publication:
09 2019
Historique:
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 30 10 2019
Statut: ppublish

Résumé

The following consensus report is based on four background reviews. The frequency of maintenance visits is based on patient risk indicators, homecare compliance and prosthetic design. Generally, a 6-month visit interval or shorter is preferred. At these visits, peri-implant probing, assessment of bleeding on probing and, if warranted, a radiographic examination is performed. Diagnosis of peri-implant mucositis requires: (i) bleeding or suppuration on gentle probing with or without increased probing depth compared with previous examinations; and (ii) no bone loss beyond crestal bone level changes resulting from initial bone remodelling. Diagnosis of peri-implantitis requires: (i) bleeding and/or suppuration on gentle probing; (ii) an increased probing depth compared with previous examinations; and (iii) bone loss beyond crestal bone level changes resulting from initial bone remodelling. If diagnosis of disease is established, the inflammation should be resolved. Non-surgical therapy is always the first choice. Access and motivation for optimal oral hygiene are key. The patient should have a course of mechanical therapy and, if a smoker, be encouraged not to smoke. Non-surgical mechanical therapy and oral hygiene reinforcement are useful in treating peri-implant mucositis. Power-driven subgingival air-polishing devices, Er: YAG lasers, metal curettes or ultrasonic curettes with or without plastic sleeves can be used to treat peri-implantitis. Such treatment usually provides clinical improvements such as reduced bleeding tendency, and in some cases a pocket-depth reduction of ≤ 1 mm. In advanced cases, however, complete resolution of the disease is unlikely.

Identifiants

pubmed: 31478575
doi: 10.1111/idj.12490
pmc: PMC9379037
doi:

Substances chimiques

Dental Implants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-17

Subventions

Organisme : International Congress of Oral Implantologists

Informations de copyright

© 2019 FDI World Dental Federation. Published by John Wiley & Sons Ltd.

Références

Implant Dent. 2019 Apr;28(2):150-154
pubmed: 30913110
J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71
pubmed: 25495683
J Clin Periodontol. 2018 Jun;45 Suppl 20:S286-S291
pubmed: 29926491
Implant Dent. 2019 Apr;28(2):144-149
pubmed: 30807404
J Clin Periodontol. 2018 Jun;45 Suppl 20:S278-S285
pubmed: 29926496
J Clin Periodontol. 2008 Sep;35(8 Suppl):282-5
pubmed: 18724855
Implant Dent. 2019 Apr;28(2):161-172
pubmed: 30601226
J Periodontol. 2010 Feb;81(2):231-8
pubmed: 20151801
J Clin Periodontol. 2012 Feb;39 Suppl 12:207-23
pubmed: 22533958
Implant Dent. 2019 Apr;28(2):155-160
pubmed: 30913111

Auteurs

Stefan Renvert (S)

Oral Health Sciences, Kristianstad University, Kristianstad, Sweden.
School of Dental Science, Trinity College, Dublin, Ireland.
Blekinge Institute of Technology, Karlskrona, Sweden.
Faculty of Dentistry, The University of Hong Kong, Hong Kong City, Hong Kong.

Hideaki Hirooka (H)

Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Miyagi, Japan.
Sweden Dental Center, Tokyo, Japan.

Ioannis Polyzois (I)

Department of Restorative Dentistry and Periodontology, Trinity College, Dublin Dental University Hospital, Dublin, Ireland.

Anastasia Kelekis-Cholakis (A)

Division of Periodontics, Dr Gerald Niznick College of Dentistry, University of Manitoba, Winnipeg, MB, Canada.

Hom-Lay Wang (HL)

Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH